Damon Silvestry
2020
In 2020, Damon Silvestry earned a total compensation of $1.8M as Chief Operating Officer at BIORA THERAPEUTICS.
Compensation breakdown
| Non-Equity Incentive Plan | $53,320 |
|---|---|
| Option Awards | $870,152 |
| Salary | $246,154 |
| Stock Awards | $611,250 |
| Other | $39,162 |
| Total | $1,820,038 |
Silvestry received $870.2K in option awards, accounting for 48% of the total pay in 2020.
Silvestry also received $53.3K in non-equity incentive plan, $246.2K in salary, $611.3K in stock awards and $39.2K in other compensation.
Rankings
In 2020, Damon Silvestry's compensation ranked 5,955th out of 13,090 executives tracked by ExecPay. In other words, Silvestry earned more than 54.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,955 out of 13,090 | 55th |
Division Manufacturing | 2,451 out of 5,624 | 56th |
Major group Chemicals And Allied Products | 979 out of 2,257 | 57th |
Industry group Drugs | 847 out of 1,957 | 57th |
Industry Pharmaceutical Preparations | 629 out of 1,462 | 57th |
Source: SEC filing on April 15, 2021.
Silvestry's colleagues
We found two more compensation records of executives who worked with Damon Silvestry at BIORA THERAPEUTICS in 2020.